ReviewReumatologia2026
Sarcoma in patients with systemic lupus erythematosus. A systematic review.
Review in Reumatologia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The risk of neoplasm is elevated in patients with various autoimmune diseases. Although the overall risk of cancer in systemic lupus erythematosus (SLE) patients is slightly elevated, the standardized incidence ratio of several cancers is above 3.0. The main risk factor for neoplasm in this group is dysfunction of the immune system caused by the disease and by immunosuppressive drugs. The most common cancers in patients with SLE are related to viral latent infections caused by human herpesvirus 8, Epstein-Barr virus, and human papillomavirus. The risk of sarcoma has not been established in large cohort studies, but several case reports have been published. It remains uncertain whether there is a direct relationship between sarcoma and SLE. We performed a systematic review of case reports and case series and analyzed the detailed data of 26 SLE patients with sarcoma. The most common sarcomas were Kaposi's sarcoma and leiomyosarcoma - 2 neoplasms that are potentially related to viral infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.